Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
A 14-year international consensus effort involving 56 professional and patient organizations has renamed polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome, a shift designed to better reflect the condition’s systemic hormonal and metabolic pathophysiology.
Endocrinology, Diabetes, Metabolism June 2nd 2026
Healthline
A randomized phase II trial in 240 premenopausal women evaluated whether low-dose (Z)-endoxifen could reduce mammographic breast density with improved tolerability compared with standard tamoxifen prevention regimens.
Family Medicine/General Practice May 20th 2026
Toxicological Sciences
A mechanistic compartmental model integrating menstrual fluid binding data estimated that less than 0.3% of theoretically released lead from tampons would be available for vaginal tissue absorption under a four-hour wear scenario.
A Reddit thread among clinicians revisits the persistent gap between cervical neuroanatomy and analgesic practice during colposcopy, with peer perspectives reflecting evolving expectations around procedural pain.
Conexiant
An international consensus involving more than 14,000 patients and health professionals renamed polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome (PMOS) to reflect its endocrine and metabolic features.
Endocrinology, Diabetes, Metabolism May 20th 2026
Journal of Women’s Health
A clinical review outlines how OBGYNs can integrate GLP-1 receptor agonist therapy into obesity care for women of reproductive age, with attention to fertility, contraception, and adherence.
Obstetrics & Gynecology May 20th 2026